KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Pacific Biosciences Of California (PACB) Receivables - Other (2016 - 2017)

Pacific Biosciences Of California has reported Receivables - Other over the past 6 years, most recently at $755000.0 for Q3 2017.

  • Quarterly results put Receivables - Other at $755000.0 for Q3 2017, changed N/A from a year ago — trailing twelve months through Sep 2017 was $755000.0 (changed N/A YoY), and the annual figure for FY2016 was $5.0 million, down 50.0%.
  • Receivables - Other for Q3 2017 was $755000.0 at Pacific Biosciences Of California, roughly flat from $755000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for PACB hit a ceiling of $10.0 million in Q4 2015 and a floor of $3000.0 in Q4 2013.
  • Median Receivables - Other over the past 4 years was $2.4 million (2017), compared with a mean of $3.4 million.
  • Biggest five-year swings in Receivables - Other: plummeted 99.63% in 2013 and later crashed 50.0% in 2016.
  • Pacific Biosciences Of California's Receivables - Other stood at $3000.0 in 2013, then soared by 333233.33% to $10.0 million in 2015, then crashed by 50.0% to $5.0 million in 2016, then tumbled by 84.9% to $755000.0 in 2017.
  • The last three reported values for Receivables - Other were $755000.0 (Q3 2017), $755000.0 (Q2 2017), and $2.4 million (Q1 2017) per Business Quant data.